Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age from 30 to 60 years all genders willing to give written consent for participation and able to understand Bengali/ English/ Hindi HbA1c more than 6.5% less than 8 % Fbs more than 126 mg/dL less than 250 mg/dL Ppbs more than 200 mg/dL less than 350 mg/dL Patients with symptoms of Cephalandra indica
Exclusion criteria
Exclusion criteria: Patients aged below 30 and above 60 years Patients having severe complications like hypoglycaemic coma retinopathy malignancy etc Immunocompromised patients suffering from HIV TB or psychiatric illness or under any antihypertensive anti diabetic or steroid medication or taking homeopathic medicine for any other systemic disorder in the last 3 months Patients not willing to give written consent or undergo any investigation as well as pregnant and lactating mothers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cephalandra indica causes significant reduction in serum HbA1c levels in patients suffering from Type 2 Diabetes mellitusTimepoint: Baseline 3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Cephalandra indica in centesimal potency causes significant changes in serum FBS, PPBS levels in patients of Diabetes mellitus type 2 Cephalandra indica in centesimal potency causes significant changes in the score of quality of life questionnaire SF36 Causal relationship is established between intervention and outcome through MONARCHTimepoint: Baseline 3 months and 6 months | — |
Countries
India
Contacts
National Institute of Homoeopathy